Description
RADIOPHARMACEUTICAL ISOTOPES
First action · last action
2009-10-01 · 2012-10-23
Transactions
6
First transaction's obligation
$0
Base + all options value (sum of deltas)
$1,076,954
Extent competed
FULL AND OPEN COMPETITION AFTER EXCLUSION OF SOURCES
Other than full & open authority
—
Set-aside
NO SET ASIDE USED.
Offers received
1
SDVOSB flag on record
No
NAICS
325188 · ALL OTHER BASIC INORGANIC CHEMICAL MANUFACTURING
Modification chain · 6 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2009-10-01+$0= $0
- Mod 12009-11-13+$0= $0
- Mod 22010-08-09+$0= $0
- Mod 32010-12-02+$0= $0
- Mod 42011-11-23+$0= $0
- Mod P000052012-10-23+$0= $0
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2009-10-01 | +$0 | $0 | RADIOPHARMACEUTICAL ISOTOPES |
| Mod 1· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2009-11-13 | +$0 | $0 | RADIOPHARMACEUTICAL ISOTOPES |
| Mod 2· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2010-08-09 | +$0 | $0 | RADIOPHARMACEUTICAL ISOTOPES |
| Mod 3· EXERCISE AN OPTION | 2010-12-02 | +$0 | $0 | RADIOPHARMACEUTICAL ISOTOPES - OPTION 1 |
| Mod 4· EXERCISE AN OPTION | 2011-11-23 | +$0 | $0 | RADIOPHARMACEUTICAL ISOTOPES - OPTION YEAR 2 FY12 FOR ZERO DOLLARS. DO/TO PERFORMED FOR FUNDING REPORT. |
| Mod P00005· EXERCISE AN OPTION | 2012-10-23 | +$0 | $0 | RADIOPHARMACEUTICAL ISOTOPES |
Related awards · 7
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI CWN9UGL3NCL9)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C24226N0711 | 242-NETWORK CONTRACT OFFICE 02 (36C242) · 3650 · CHEMICAL AND PHARMACEUTICAL PRODUCTS MANUFACTURING MACHINERY | $100,008 | FY2026 |
| 36C24126P0328 | 241-NETWORK CONTRACT OFFICE 01 (36C241) · 6505 · DRUGS AND BIOLOGICALS | $999,797 | FY2026 |
| 36C25726N0407 | 257-NETWORK CONTRACT OFFICE 17 (36C257) · 6505 · DRUGS AND BIOLOGICALS | $1,400,000 | FY2026 |
| 36C25526N0361 | 255-NETWORK CONTRACT OFFICE 15 (36C255) · 6505 · DRUGS AND BIOLOGICALS | $228,679 | FY2026 |
| 36C24426N0938 | 244-NETWORK CONTRACT OFFICE 4 (36C244) · 6505 · DRUGS AND BIOLOGICALS | $650,641 | FY2026 |
| 36C24426D0097 | 244-NETWORK CONTRACT OFFICE 4 (36C244) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2026 |
Other recipients under Q527 from 564-FAYETTEVILLE (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| VA564C00239 | CANCER CAREPOINT, INC. | 564-FAYETTEVILLE | $10,013 | FY2010 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_IDV_VA256P0669_3600 · retrieved 2026-09-26.